Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to patients. They are a drug turnaround biotech that acquires small molecules with safety issues, using AI to optimize the drug discovery process and reduce safety-related risks.
- Category
- AI Drug Discovery
- Stage
- Seed
- Employees
- 9
- HQ
- Cambridge, United Kingdom
- Founded
- 2021
- Funding
- $8M